U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06819670) titled 'A Study to Prevent Infantile Spasms Relapse' on Jan. 29.
Brief Summary: After initially successful treatment, many children with infantile spasms unfortunately have a relapse, and relapse is linked to poor long-term outcomes such as autism and other forms of epilepsy. The aim of this study is to determine if treatment with low-dose prednisolone is safe, well tolerated, and effective in reducing the risk of relapse.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Infantile Spasms
Infantile Epileptic Spasms Syndrome
West Syndrome
Intervention:
DRUG: Prednisolone
active drug
DRUG: Famotidine
active drug
DRUG:...